REGAINE

This brand name is authorized in Austria, Cyprus, Estonia, Hong Kong SAR China, Ireland, Lithuania, Malta, New Zealand, Romania, Singapore, South Africa, Spain, UK.

Active ingredients

The drug REGAINE contains one active pharmaceutical ingredient (API):

1	Minoxidil UNII 5965120SH1 - MINOXIDIL
	Topical administration of minoxidil stimulates hair growth in men and women with androgenic alopecia. The mechanism of stimulating hair growth from minoxidil is not fully understood, but some actions of minoxidil include increasing hair diameter, stimulating new growth and prolonging the developmental phase, and stimulating hair follicle transition from resting phase (telogen) in the growth phase (regenerative).
	Read more about Minoxidil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
REGAINE FOAM Cutaneous foam	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D11AX01	Minoxidil	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1022353, 1022364, 1787676, 1820124
ES	Centro de información online de medicamentos de la AEMPS	76483
GB	Medicines & Healthcare Products Regulatory Agency	185507, 185508, 320666, 358555, 95241, 95254, 95255
HK	Department of Health Drug Office	52159, 52160, 52161, 64008, 65139
LT	Valstybinė vaistų kontrolės tarnyba	1008746, 1008747
MT	Medicines Authority	AA908/13603, MA1315/00601, MA1377/00101, PI908/13601A
NZ	Medicines and Medical Devices Safety Authority	14343, 17485, 2619
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65436001, W65436002, W67162001, W67162002
SG	Health Sciences Authority	04399P, 08213P
ZA	Health Products Regulatory Authority	U/13.4.2/140, Y/13.4.2/31